No Picture
News

Catalyst Biosciences Announces CFI Variant Presentations at Two Upcoming Scientific Conferences

SOUTH SAN FRANCISCO, Calif., Oct. 29, 2021 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that Grant Blouse, Ph.D., chief scientific officer, will present at two upcoming scientific conferences, the 5th Complement-based D… […]

No Picture
News

Coherus BioSciences to Report Third Quarter 2021 Financial Results on November 8th

REDWOOD CITY, Calif., Oct. 29, 2021 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its third quarter 2021 financial results will be released after market close on Monday, November 8, 2021. Starting at 5 p…. […]

No Picture
News

Real-world evidence on Gilead’s HIV combo Biktarvy confirms high efficacy; Digital therapeutics firm to trade on Nasdaq

Gilead on Friday announced interim results from an ongoing, real-world trial for its HIV drug Biktarvy, confirming its effectiveness in more than 1,100 people living with HIV, and analyzing patient-reported outcomes too. The FDA approved Biktarvy in 20… […]

No Picture
News

BridgeBio Pharma Announces Collaborations with Columbia University and Mount Sinai to Develop Potential Therapies for Genetic Diseases and Cancers

PALO ALTO, Calif.: PALO ALTO, Calif., Oct. 29, 2021 /PRNewswire/ — BridgeBio Pharma, Inc. (Nasdaq: BBIO), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced two new academic collaborations with Columb… […]

No Picture
News

Only a pawn in their game: Orphan drug tax credit on the chopping block again under Dem spending bill

Buried about 1,600 pages into the version of the Build Back Better Act released yesterday afternoon is a pronounced tweak to the orphan drug tax credit that would sharply curtail which clinical testing expenses qualify for the credit. The change comes … […]

No Picture
News

Alnylam’s John Maraganore isn’t the only CEO to leave his post; CRISPR’s chief commercial officer takes the helm at a protein degradation player

John Maraganore The departure of a number of CEOs is the prevailing theme that kicks off this week’s installment: In a stunner, Alnylam CEO John Maraganore announced that Yvonne Greenstreet will be his successor at the end of the year. Maraganore, the … […]

No Picture
News

National Corn Growers Association Announces Winners of the Consider Corn Challenge III Contest

ST. LOUIS: ST. LOUIS, Oct. 28, 2021 /PRNewswire/ — Today, the National Corn Growers Association (NCGA) announced the Consider Corn Challenge III winners at the Advanced Biofuels Leadership Conference in San Francisco, California. The six winners were … […]

No Picture
News

CohBar Announces Pricing of $15.0 Million Public Offering of Common Stock and Warrants

MENLO PARK, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR) (the “Company”), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, today announced … […]